| Literature DB >> 35566390 |
Jameel M Al-Khayri1, Wudali N Sudheer2, Vasantha V Lakshmaiah2, Epsita Mukherjee3, Aatika Nizam4, Muthu Thiruvengadam5, Praveen Nagella2, Fatima M Alessa6, Muneera Q Al-Mssallem6, Adel A Rezk1, Wael F Shehata1, Mahesh Attimarad7.
Abstract
Artemisinin is an anti-malarial sesquiterpene lactone derived from Artemisia annua L. (Asteraceae family). One of the most widely used modes of treatment for malaria is an artemisinin-based combination therapy. Artemisinin and its associated compounds have a variety of pharmacological qualities that have helped achieve economic prominence in recent years. So far, research on the biosynthesis of this bioactive metabolite has revealed that it is produced in glandular trichomes and that the genes responsible for its production must be overexpressed in order to meet demand. Using biotechnological applications such as tissue culture, genetic engineering, and bioreactor-based approaches would aid in the upregulation of artemisinin yield, which is needed for the future. The current review focuses on the tissue culture aspects of propagation of A. annua and production of artemisinin from A. annua L. cell and organ cultures. The review also focuses on elicitation strategies in cell and organ cultures, as well as artemisinin biosynthesis and metabolic engineering of biosynthetic genes in Artemisia and plant model systems.Entities:
Keywords: Agrobacterium rhizogenes; Artemisia annua; Artemisinin; bioreactor; cell suspension culture; elicitation
Mesh:
Substances:
Year: 2022 PMID: 35566390 PMCID: PMC9103073 DOI: 10.3390/molecules27093040
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
In vitro regeneration of Artemisia annua through direct organogenesis from various explants.
| Explant | Media | Response | References |
|---|---|---|---|
| Seed | MS + 0.1 ppm BA + 1.0 ppm NAA | Shooting | [ |
| Inflorescence | MS + 1.0 mg/L BAP + 2.0 mg/L IBA | Multiple shooting | [ |
| Stem | MS + 0.1 mg/L TDZ | Multiple shooting | [ |
| Leaf, petiole | MS + 1.0 mg/L TDZ | Shooting and rooting | [ |
| Seed | MS + 0.1 mg/L KN + 0.01 mg/L NAA | Shooting | [ |
| Nodal stem explants | MS + 0.2 mg/L NAA + 0.2 mg/L BAP | Multiple shooting | [ |
| Nodal stem explants | Shooting: MS + 4.44 µM BAP Rooting: ½ MS + 2.46 µM IBA | Multiple shooting and rooting | [ |
| Nodal stem explants | Shooting: MS + 10.0 µM 2-iP; Rooting: 1/2 MS + 5.0 µM NAA | Multiple shooting and rooting | [ |
| Nodal stem explants | Shooting: MS + 0.8 mg/L BAP + 0.1 mg/L IBA; Multiplication medium: MS + 1.0 mg/L BAP + 0.1 mg/L IBA; Rooting: 1/2 MS + 0.5 mg/L IBA | Multiple shooting and rooting | [ |
| Leaf | Shooting: MS + 1.0 mg/L BAP + 0.05 mg/L NAA + 2.0 mg/L AgNO3 | Shoot regeneration | [ |
| Leaf | Shooting: MS + 0.5 mg/L NAA + 2.0 mg/L BA; Rooting: MS + 0.1 mg/L IBA | Shooting and rooting | [ |
| Seed | Shooting: MS + 4.4 µM BA + 0.35 µM IBA; Multiplication medium: MS + 0.9 µM BA + 0.05 µM NAA | Shooting and multiplication | [ |
In vitro regeneration of Artemisia annua through indirect organogenesis from various explants.
| Explant | Media | Response | References |
|---|---|---|---|
| Leaf, hypocotyl | Callus: MS + 5.4 µM NAA; Shooting: MS + 13.32 µM BA + 1.08 µM NAA | Callusing and organogenesis | [ |
| Hypocotyl | Callusing and shooting: MS + 0.5 µM NAA + 13 µM BAP + 0.3 µM GA3 | Callusing and multiple shooting | [ |
| Leaf | Callusing: MS + 0.1 mg/L BAP + 0.05 mg/L NAA; Shooting: 0.4 mg/L BAP + 0.2 mg/L NAA | Callusing and multiple shooting | [ |
| Leaf | Callusing: MS + 1.0 mg/L BAP + 0.05 mg/L NAA | Callusing and organogenesis | [ |
| Leaf | Callusing: MS + 0.5 mg/L NAA or 2,4-D + 0.5 mg/L BAP; Shooting: 0.25 mg/L NAA + 1.0 mg/L BAP; Rooting: ½ MS + 0.1 mg/L IBA | Callusing and organogenesis | [ |
Figure 1Biosynthetic pathway for the production of Artemisinin from Artemisia annua.
Various biotic and abiotic elicitors and culture conditions used for the production of artemisinin.
| Elicitor | Culture Type | Culture | Yield of | Reference |
|---|---|---|---|---|
|
| ||||
| Cell wall’s oligosaccharide from | Hairy root culture | MS medium + 20 mg/L elicitor | Increased by 68.29% | [ |
| Cerebroside from fungal source | Hairy root culture | MS medium + 10–70 µg/mL cerebroside | Increased by 2.3 folds | [ |
| Oligosaccharide from | Hairy root culture | MS medium + 0.3 mg total sugar/mL elicitor | Increased from 0.7 mg/g DW to 1.3 mg/g DW | [ |
| Mycelial extract of | Hairy root culture | MS medium + 0.4 mg total sugar/mL elicitor | Increased from 0.8 mg/g DW to 1 mg/g DW | [ |
| In vitro grown Rooted plantlets | MS medium + 5.0 mg/L BAP + 1.0 mg/L NAA + | Increased by 43.5% | [ | |
|
| ||||
| Ag-SiO2 nanoparticles | Hairy root culture | MS medium + 900 mg/L nano elicitor | Increased by 3.9 folds | [ |
| Chitosan nanoparticles | Cell suspension culture | MS medium + 0.5 mg/l NAA + 0.5 mg/L BAP + 15 mg/L Elicitor | NA | [ |
| Cobalt nano particles | Callus culture | MS medium + 0.5 mg/L NAA + 0.5 mg/L BAP + 5 mg/L elicitor | Increased by 2.25 folds | [ |
| Chitosan | Hairy root culture | MS medium + 150 mg/L chitosan | Increased by 6 folds | [ |
| Oligogalacturonides | Hairy root culture | MS medium + 0.01 mg/L gibberellic acid +60 g/mL elicitor | Increased by 55.2% | [ |
| Heptakis (2,6-di-O-methyl)-β-cyclodextrin (DIMEB) and methyl jasmonate | Cell suspension culture | MS medium + 2.0 mg/L 2,4-D + 0.15 mg/L BAP + 50 mM DIMEB + 100 µM Methyl jasmonate | Increased by 300 folds (27 umol/g DW) | [ |
| Methyl jasmonate and mevalonic acid lactone | Cell suspension culture | MS medium + 0.1 mg/L NAA + 0.1 mg/L KN + 50 mg/L mevalonic acid lactone + methyl jasmonate | Increased by 5.93 times | [ |
| Sorbitol and Coronatine | Cell suspension culture | MS medium + 0.1 mg/L NAA + 0.1 mg/L KN + 30 g/L Sorbitol + 0.05 µM Coronatine | Increased by 8 folds | [ |
Bioreactors and culture conditions for the production of artemisinin.
| Culture Type | Type of Bioreactor | Culture Conditions | Yield | References |
|---|---|---|---|---|
| Hairy root culture | Modified nutrient mist bioreactor | ¼ MS + 10 µg/L GA3Batch culture having adequate oxygen supply and nutrient | 1.12 mg/g | [ |
| Shoot culture | Mist bioreactor | MS + 0.05 mg/L NAA + 0.5 mg/L BAP; 25 days batch | 48.2 mg/L | [ |
| Shoot culture | Mist nutrient bioreactor | MS + 0.05 mg/L NAA + 0.5 mg/L BAP; 25 days batch | 46.9 mg/L | [ |
| Hairy root culture | Mist nutrient bioreactor | B5 medium; 1 min on/15 min off mist cycle | NA | [ |
| Hairy root culture | Modified stirred tank bioreactor | ¼ MS + 10 µg/L GA3; Fed batch for 10–15 days | 0.99 mg/g DW | [ |
| Hairy root culture | Stirred tank bioreactor | MS medium; 25-day batch. | 0.32 mg/g DW | [ |
| Adventitious roots | Mist bioreactor | MS medium; 0.5 L/min air, 25-day culture | 46.9 mg DW/L | [ |